Table 1.
RA (n = 47) | SLE (n = 32) | Control (n = 47) | P | |
Age, mean ± SD | 52.1 ± 11.9 | 41.4 ± 14.5 | 47.2 ± 17.3 | 0.01 |
Female, n (%) | 39 (83.0) | 27 (84.4) | 36 (80.0) | 0.87 |
Diabetes, n (%) | 4 (8.5) | 1 (3.1) | 5 (11.1) | 0.44 |
Hypertension, n (%) | 19 (40.4) | 10 (31.3) | 12 (26.7) | 0.36 |
Dyslipidemia, n (%) | 9 (19.1) | 1 (3.1) | 6 (13.3) | 0.11 |
Smoking, n (%) | 14 (29.8) | 12 (37.5) | 13 (28.9) | 0.69 |
BMI, mean ± SD | 27.9 ± 5.0a | 25.8 ± 4.9b | 26.2 ± 4.6 | 0.13 |
CRP, mg/dLc | 0.6 (0.1–4.2) | 0.4 (0.1–20.6) | n/a | 0.05* |
BMI: Body mass index; CRP: C-reactive protein; n/a: not available; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; a: 1, b: 2 missing data; c: median and min–max. *: CRP value is only available for RA and SLE patients. Bold font indicates statistically significant difference.